Fulcrum Capital LLC Purchases 1,470 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fulcrum Capital LLC grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 3.1% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 49,666 shares of the exchange traded fund’s stock after purchasing an additional 1,470 shares during the quarter. Fulcrum Capital LLC owned approximately 0.07% of SPDR S&P Biotech ETF worth $4,473,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also modified their holdings of XBI. ST Germain D J Co. Inc. bought a new stake in SPDR S&P Biotech ETF in the fourth quarter valued at approximately $108,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of SPDR S&P Biotech ETF by 1.6% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 120,504 shares of the exchange traded fund’s stock valued at $11,906,000 after purchasing an additional 1,941 shares during the period. Marotta Asset Management lifted its holdings in shares of SPDR S&P Biotech ETF by 2.0% in the fourth quarter. Marotta Asset Management now owns 63,196 shares of the exchange traded fund’s stock valued at $5,784,000 after purchasing an additional 1,266 shares in the last quarter. Fortitude Family Office LLC acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter worth about $117,000. Finally, Synovus Financial Corp grew its holdings in shares of SPDR S&P Biotech ETF by 110.9% during the third quarter. Synovus Financial Corp now owns 9,391 shares of the exchange traded fund’s stock worth $928,000 after buying an additional 4,939 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI traded down $1.03 during trading hours on Monday, reaching $88.41. 11,410,731 shares of the stock were exchanged, compared to its average volume of 8,663,956. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm has a 50 day moving average of $95.48 and a 200 day moving average of $97.12. The stock has a market cap of $6.74 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.